Healthcare
Colleen Cuffaro
Partner / East Coast
Since 2014
Colleen’s investment focus is early stage biopharmaceutical companies. In her time at Canaan, Colleen helped launch the Canaan-Yale Fellowship program. Since 2017, she serves on the board of the New England Venture Capital Association. Colleen previously worked as a chemist at PMRS, Inc (Pharmaceutical Manufacturing and Research Services, Inc). She holds a Ph.D. in Cellular and Molecular Physiology from Yale University and a B.A. in Chemistry from the University of Pennsylvania.
Colleen in 5
Origins: Born & raised in Philadelphia
Travel: I love exploring new places, ideally by bicycle (Italy is #1 so far)
Family: House full of boys
Interests: Time with my family, swimming, biking and running
Accomplishments: 4X Ironman finisher
Investments
Current
Latest
Annual Women Who Venture Gathering 2020
Announcing three team promotions
FierceBiotech: Canaan-backed Comet uncloaks with $28.5M and biopharma vet De Graaf at the helm
STAT News: Arrakis' lofty goal: Kill cancer with pills that target RNA instead of proteins
Endpoints News: The Endpoints 11: A group of disruptive upstarts on a do-or-die mission to launch new meds
Business Insider: Meet the 30 biotech leaders under 40 who are shaping the future of medicine
Fierce Biotech: Canaan unveils $800 million fund for fresh wave of biotech bets
STAT: Biotech dreams of drugging the “undruggable”
GrowthCap: Top 40 Under 40 Growth Investors Of 2017
Genetic Engineering and Biotech News: Narrowing boardroom diversity divide
Colleen Cuffaro: Arrakis Therapeutics: Redefining the druggable target
Colleen in 5
Origins: Born & raised in Philadelphia
Travel: I love exploring new places, ideally by bicycle (Italy is #1 so far)
Family: House full of boys
Interests: Time with my family, swimming, biking and running
Accomplishments: 4X Ironman finisher